NSE:IPCALAB
Ipca Laboratories Limited · NSE · Healthcare · INR · FY for 2026
Figures on this page computed 2026-11-08 13:28 UTC
Last close
n/aINR
Market data
43.2xP/E
Price / Earnings per Share (diluted)
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- INR
- computed
- Computed from the filing for 2026
21.2%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- INR
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
11.8%Net margin
Net Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- INR
- Computed from the filing for 2026
- Computed from the filing for 2026
5.0%FCF margin
Free Cash Flow / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- INR
- Computed from the filing for 2026
- Computed from the filing for 2026
0.10Debt/equity
Total Debt / Shareholders' Equity
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- INR
- Computed from the filing for 2026
- Computed from the filing for 2026
0.1%Dividend yield
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- INR
- computed
Price is the furthest below its sector's middle: 0.19 against 0.36 on the market's range.
Follow one rupee
lens 1 of 9After what it costs to make
64.1%
After running the business
24.2%
After interest and tax
11.8%
After what it must reinvest
5.0%
Kept after the dividend
4.5%
The five stops
5 of 5 read- After what it costs to make61,833,100,00064.1%
- After running the business23,315,800,00024.2%
- After interest and tax11,411,200,00011.8%
- After what it must reinvest4,860,200,0005.0%
- Kept after the dividend4,336,100,0004.5%
Of every unit of sales, 0.04 is still there after the dividend.
Of every unit of sales, 0.04 is still there after the dividend.
Every figure in this lens
Except where said otherwise: Computed from the filing for 2026
Sales96,463,300,000
- Source
- computed
- Statement
- income
- Fiscal year
- 2026
- Reported in
- INR
After what it costs to make61,833,100,000
- Source
- computed
- Statement
- income
- Fiscal year
- 2026
- Reported in
- INR
After running the business23,315,800,000
- Source
- computed
- Statement
- income
- Fiscal year
- 2026
- Reported in
- INR
After interest and tax11,411,200,000
- Source
- computed
- Statement
- income
- Fiscal year
- 2026
- Reported in
- INR
After what it must reinvest4,860,200,000
- Source
- computed
- Statement
- income
- Fiscal year
- 2026
- Reported in
- INR
Kept after the dividend4,336,100,000
- Source
- computed
- Statement
- income
- Fiscal year
- 2026
- Reported in
- INR